Search Within

Ghassan Abou-Alfa

Formats
  1. Meeting Abstract (268)
  2. Journal Article (247)
  3. Review (27)
  4. Book Section (16)
  5. Editorial (8)
  6. Book Whole (4)
  7. Correspondence (4)
  8. Guidelines (4)
  9. Miscellaneous (3)
  10. Research Letter (1)
Groups
  1. Department of Medicine (582)
  2. Gastrointestinal Oncology Service (582)
  3. Solid Tumor Oncology Division (582)
  4. Center for Pancreatic Cancer Research (218)
  5. Epidemiology and Biostatistics (124)
  6. Surgery (103)

More Groups

People
  1. Eileen O'Reilly (159)
  2. James Harding (134)
  3. Marinela Capanu (67)
  4. William Jarnagin (66)
  5. Leonard Saltz (55)
  6. Imane El Dika (54)

More People

Years
  1. 2025 (27)
  2. 2024 (52)
  3. 2023 (48)
  4. 2022 (53)
  5. 2021 (46)
  6. 2020 (46)

More Years

Publications
  1. Journal of Clinical Oncology (167)
  2. Annals of Oncology (57)
  3. Gastrointestinal Cancer Research (21)
  4. Oncology Research and Treatment (18)
  5. Annals of Surgical Oncology (15)
  6. Cancer (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (183)
  2. Oxford University Press (69)
  3. Springer (36)
  4. Wiley Blackwell (30)
  5. Elsevier Inc. (25)
  6. Elsevier Science, Inc. (24)

More Publishers

Results (582)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • IDH2-mutated cholangiocarcinoma: A case series highlighting challenges and insights
    Meeting Abstract

    Al Mahmasani, L.; Harding, J. J.; Thummalapalli, R.; Khalil, D.; Yaqubie, A.; O'Reilly, E. M.; Abou-Alfa, G. K.
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • Botensilimab plus balstilimab in an expanded cohort of 123 patients with metastatic microsatellite-stable colorectal cancer and no active liver metastases
    Meeting Abstract

    Schlechter, B. L.; Fakih, M.; Tsimberidou, A. M.; Bullock, A.; Pimentel, A.; Sharma, S.; Lenz, H. J.; Gordon, M.; Abou-Alfa, G. K.; Marron, T.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • Body mass index and somatic variants in biliary tract cancers
    Meeting Abstract

    Al Mahmasani, L.; Chou, J.; Capanu, M.; Srivastava, A.; Sigel, C.; Alsuwailem, R.; Berger, M.; Khalil, D.; Harding, J. J.; O'Reilly, E. M.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • Final analysis of a randomized, double blind, phase II study of sorafenib with or without YIV-906 in patients with advanced HCC
    Meeting Abstract

    Abou-Alfa, G. K.; Yen, Y.; Harding, J. J.; Whang-Peng, J.; Shi, Y. K.; Yuen, M. F.; Li, X.; Gu, S.; Liu, C.; Jeng, L. B.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • Comparative effectiveness of immunotherapy versus lenvatinib in advanced hepatocellular carcinoma: A real-world analysis using target trial emulation
    Journal Article

    Ahn, J. C.; Ng, W. H.; Yeo, Y. H.; Kim, H. S.; Wang, Y.; Trivedi, H.; Ayoub, W. S.; Kuo, A.; Rich, N.; Parikh, N. D.; more...
    Hepatology (2025)

    Fulltext@MSK | Save
  • Microbial diversity associated with nail toxicities in fibroblast growth factor receptor inhibitor treated patients
    Meeting Abstract

    Bang, A. S.; Gordon, A.; Jhaveri, K.; Rosenberg, J. E.; O'Donohue, T.; Sait, S. F.; Funt, S. A.; Abou-Alfa, G. K.; Iyer, G. V.; Lacouture, M. E.
    Journal of the American Academy of Dermatology (2025)

    Fulltext@MSK | Save
  • Body mass index and somatic variants in biliary tract cancers
    Meeting Abstract

    Al Mahmasani, L.; Chou, J. F.; Capanu, M.; Srivastava, A.; Sigel, C. S.; Alsuwailem, R.; Berger, M. F.; Khalil, D. N.; Harding, J. J.; O'Reilly, E. M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable hepatocellular carcinoma: HIMALAYA Phase 3 randomized clinical trial
    Journal Article

    Lau, G.; Sangro, B.; Cheng, A. L.; Kudo, M.; Kelley, R. K.; Tak, W. Y.; Gasbarrini, A.; Reig, M.; Lim, H. Y.; Tougeron, D.; more...
    Hepatology (2025)

    Fulltext@MSK | Save
  • Immune-related adverse events are associated with improved outcomes after immune checkpoint inhibitor treatment in hepatocellular carcinoma: A systematic review and meta-analysis
    Review

    Hwang, S. Y.; Rezaee-Zavareh, M. S.; Attia, A. M.; Kaymen, E. A.; Tran, N.; Abou-Alfa, G. K.; Parikh, N. D.; Singal, A. G.; Yang, J. D.
    American Journal of Gastroenterology (2025)

    Fulltext@MSK | Save
  • The Lancet Commission on addressing the global hepatocellular carcinoma burden: Comprehensive strategies from prevention to treatment
    Review

    Chan, S. L.; Sun, H. C.; Xu, Y.; Zeng, H.; El-Serag, H. B.; Lee, J. M.; Schwartz, M. E.; Finn, R. S.; Seong, J.; Wang, X. W.; more...
    Lancet (2025)

    Fulltext@MSK | Save